BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 12713621)

  • 1. Smooth muscle cell differentiation in mammary stromo-epithelial lesions with evidence of a dual origin: stromal myofibroblasts and myoepithelial cells.
    Di Tommaso L; Pasquinelli G; Damiani S
    Histopathology; 2003 May; 42(5):448-56. PubMed ID: 12713621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myoid hamartoma of breast with chondroid metaplasia: a case report.
    Khoo JJ; Alwi RI; Abd-Rahman I
    Malays J Pathol; 2009 Jun; 31(1):77-80. PubMed ID: 19694319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Benign myofibroblastic/epithelial lesions of the breast with minimally infiltrative margins.
    Vecchio GM; Angelico G; Broggi G; Virzì V; Salvatorelli L; Magro G
    Pathol Res Pract; 2021 Oct; 226():153577. PubMed ID: 34455362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myoepithelial cell cocktail (p63+SMA) for the evaluation of sclerosing breast lesions.
    Pavlakis K; Zoubouli C; Liakakos T; Messini I; Keramopoullos A; Athanassiadou S; Kafousi M; Stathopoulos EN
    Breast; 2006 Dec; 15(6):705-12. PubMed ID: 16384708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myoid hamartomas of the breast: report of 3 cases and review of the literature.
    Filho OG; Gordan AN; Mello Rde A; Neto CS; Heinke T
    Int J Surg Pathol; 2004 Apr; 12(2):151-3. PubMed ID: 15173923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenotypic alterations in myoepithelial cells associated with benign sclerosing lesions of the breast.
    Hilson JB; Schnitt SJ; Collins LC
    Am J Surg Pathol; 2010 Jun; 34(6):896-900. PubMed ID: 20463570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mammary stromal-epithelial lesions with myofibroblastic stroma and HMGA2 overexpression linked smooth muscle differentiation, a case series from single institution.
    Abada E; Tseng Y; Sung CJ; Singh K
    Pathol Res Pract; 2023 Aug; 248():154626. PubMed ID: 37352786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical staining of papillary breast lesions.
    Troxell ML; Masek M; Sibley RK
    Appl Immunohistochem Mol Morphol; 2007 Jun; 15(2):145-53. PubMed ID: 17525625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Myoid/myofibroblastic differentiation in dermatofibrosarcoma protuberans: a clinicopathologic study of six cases].
    Wang J; Zhu X; Yosuke M; Masanori H; Hiroshi H
    Zhonghua Bing Li Xue Za Zhi; 2001 Feb; 30(1):12-5. PubMed ID: 11866949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myoid hamartomas of the breast.
    Daroca PJ; Reed RJ; Love GL; Kraus SD
    Hum Pathol; 1985 Mar; 16(3):212-9. PubMed ID: 3972402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bilateral myoid hamartoma of breast: an exceptionally rare lesion.
    Nangia A; Patiri K; Pujani M; Sehgal S
    Breast Dis; 2013 Jan; 34(2):77-80. PubMed ID: 23963200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myofibroblastic, fibroblastic and myoid lesions of the breast.
    Krings G; McIntire P; Shin SJ
    Semin Diagn Pathol; 2017 Sep; 34(5):427-437. PubMed ID: 28751104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular phenotypes of the human kidney: Myoid stromal cells/telocytes and myoepithelial cells.
    Rusu MC; Mogoantă L; Pop F; Dobra MA
    Ann Anat; 2018 Jul; 218():95-104. PubMed ID: 29660398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical distinction of invasive from noninvasive breast lesions: a comparative study of p63 versus calponin and smooth muscle myosin heavy chain.
    Werling RW; Hwang H; Yaziji H; Gown AM
    Am J Surg Pathol; 2003 Jan; 27(1):82-90. PubMed ID: 12502930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mammary hamartoma: immunohistochemical study of two adenolipomas and one variant with cartilage, smooth muscle and myoepithelial proliferation.
    Hayashi H; Ito T; Matsushita K; Kitamura H; Kanisawa M
    Pathol Int; 1996 Jan; 46(1):60-5. PubMed ID: 10846551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Mammary hamartoma with atypical stromal cells: a potential diagnostic dilemma].
    Agabiti S; Gurrera A; Amico P; Vasquez E; Magro G
    Pathologica; 2007 Dec; 99(6):434-7. PubMed ID: 18416336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiomatoid "malignant" fibrous histiocytoma: a clinicopathologic study of 158 cases and further exploration of the myoid phenotype.
    Fanburg-Smith JC; Miettinen M
    Hum Pathol; 1999 Nov; 30(11):1336-43. PubMed ID: 10571514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p63 expression in benign and malignant breast lesions.
    Stefanou D; Batistatou A; Nonni A; Arkoumani E; Agnantis NJ
    Histol Histopathol; 2004 Apr; 19(2):465-71. PubMed ID: 15024707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mammary NOS-type sarcoma with CD10 expression: a rare entity with features of myoepithelial differentiation.
    Leibl S; Moinfar F
    Am J Surg Pathol; 2006 Apr; 30(4):450-6. PubMed ID: 16625090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distribution of calponin and smooth muscle myosin heavy chain in fine-needle aspiration biopsies of the breast.
    Dabbs DJ; Gown AM
    Diagn Cytopathol; 1999 Apr; 20(4):203-7. PubMed ID: 10204102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.